Erlonat 150mg (Erlotinib)

Previous product
Erlonat 100mg (Erlotinib) A$281.58 A$555.94Price range: A$281.58 through A$555.94
Next product
Gemita 200mg Injection (Gemcitabine) A$46.21 A$122.74Price range: A$46.21 through A$122.74

A$323.46 A$619.48Price range: A$323.46 through A$619.48

In Stock
In Stock

Erlonat 150mg (Erlotinib)

Pack SizePricePrice / UnitQuantityAdd To Cart
30 Tablet/sA$323.46A$10.78 / Tablet
60 Tablet/sA$619.48A$10.32 / Tablet
Want to order in bulk / B2B price? Send Inquiry
×

Sorry!! Out of Stock

View All Erlotinib Products
Clear

Offer You Can't Resist

Free Shipping

Enjoy Free Shipping on Orders above AUD304 (USD199)
Estimate Shipping :
20 July - 27 July
33
SKU: N/A Categories: ,

What Our Customer Says

4.9
4.9 out of 5 stars (based on 215 reviews)

Excellent service

The website is easy to navigate, and my order arrived exactly as expected. Excellent service

Australia Australia
June 27, 2026
Last Updated on December 06, 2025
Description

Erlonat 150mg with active substance Erlotinib is a targeted therapy for cancer medicine that is used for treating certain kinds of pancreatic, lung, and squamous cell cancers. It’s part of a category of medicines that are known as tyrosine kinase inhibitors (TKIs), which can block certain proteins that allow cancerous cells to expand and multiply.

Erlotinib is transforming the treatment approach for patients who have metastatic or advanced cancers by providing a better, more targeted attack against cancerous cells. It is also associated having fewer adverse effects than conventional chemotherapy.

Let’s look into the details of Erlonat 150mg means and how it functions, as well as how it can be taken and the potential adverse effects, essential precautions to take, as well as solutions to the most frequently sought-after questions.

What is Erlonat 150mg (Erlotinib)?

Erlonat is a drug that contains Erlotinib hydrochloride, which affects the epidermal growth factor receptor (EGFR) — which is a protein located in the skin of certain cancerous cells. The EGFR is a major factor in the development and spreading of tumors in certain types.

Through reducing the activity of EGFR, Erlonat aids in slowing or even stopping the development of cancers that depend upon this pathway, specifically for cases of non-small-cell lung cancer (NSCLC) and pancreatic cancer.

How Does Erlotinib Work?

Cancer cells typically take advantage of the signals of EGFR to grow exponentially. Erlotinib is a binding agent for the EGFR’s tyrosine-kinase domain, which blocks its signaling, affecting cancer cells’ capacity to survive and grow.

This targeted approach:

  • Particularly targets tumor cells that have active EGFR mutations
  • Minimizes damage to normal, healthy cells
  • It can slow down the growth of tumors and increase survival rates for responders

Since Erlotinib is targeted at a particular molecular pathway, it can be classified as a type of targeted cancer treatment that is often administered after the first chemotherapy, or with other therapies.

Indications: When is Erlonat Used?

Erlonat 150mg can be recommended for:

  • Non-Small Cell Lung Cancer (NSCLC):
    In particular, for patients suffering from the EGFR mutation that is positive for tumors. This includes local metastatic or advanced disease. The treatment is usually administered after chemotherapy has failed or as a primary treatment when the mutation exists.
  • Pancreatic Cancer:
    Erlotinib is prescribed in conjunction with chemotherapy using gemcitabine to treat localized advanced, non-resectable, and metastatic pancreatic cancer.

Dosage and Administration

Typical Dosage for Adults:

  • 150 mg twice daily and to be taken by mouth.
  • The dosage should be consumed on an empty stomach–at minimum 1 hour before or two hours after eating for greater absorption.

Important Points:

  • Suck the tablets completely with the aid of a glass of water.
  • Use it at the same time each day to keep regular levels of the drug.
  • Don’t crush, chew, or break tablets.
  • If you are unable to take the dose, get it as quickly as you can remember it, unless it’s near the next dose scheduled. Avoid taking two doses.

Duration of Treatment

The duration of treatment for Erlonat is contingent on the individual’s response as well as tolerance. Erlonat is usually used to the extent that cancer has no adverse side effects.

Your doctor will track the progress of your treatment and could alter or discontinue treatment based on its effectiveness and the negative side effects.

Side Effects of Erlonat 150mg

Similar too many chemotherapy treatments for cancer, Erlonat can cause side effects. Many are treatable; however, others require a close watch.

Common Side Effects:

  • Skin rash: Most often, acne-like eruptions appear across the face and upper body. These can range from minor to serious.
  • Diarrhea
  • Loss of appetite
  • Fatigue
  • Nausea and vomiting
  • Dry skin or itching
  • Mouth sores

Serious Side Effects (Seek Medical Attention Immediately):

  • Severe skin reactions or blistering
  • Liver problems: Jaundice (yellowing of the skin or eyes), dark urine, severe abdominal pain
  • Interstitial lung disease (rare but serious lung inflammation)
  • Eye irritation or vision changes
  • Severe diarrhea or dehydration

If you are experiencing any of the severe symptoms or indications of allergic reactions (swelling or breathing difficulties), make sure you contact your healthcare professional immediately.

Precautions and Warnings

Before starting Erlonat:

  • Consult your doctor if you have any history of breathing issues or lung disease.
  • Inform your physician if you are suffering from kidney or liver problems.
  • Be aware of any other medication that you take, such as herbal supplements or items, to avoid dangerous interactions.
  • Beware of smoking, as it may reduce the effectiveness of Erlotinib.
  • Beware of excessive exposure to sunlight and apply sun protection. Erlotinib enhances sensitivity to light.
  • If you are pregnant or breastfeeding must discuss the risk with your physician.

Drug Interactions

Erlotinib may interact with other drugs, including:

  • Antacids and acid-reducing agents (proton pump inhibitors, H2 blockers): These drugs can lower Erlotinib absorption. It is recommended to keep the doses of these drugs.
  • CYP3A4 inducers or inhibitors: Certain drugs that alter the liver enzymes may alter Erlotinib levels in the blood.
  • Warfarin and other blood thinners: Monitor for bleeding risk.

Make sure you inform your physician of any medication you are taking.

Monitoring During Treatment

Patients who are treated at Erlonat will undergo periodic checkups. This could consist of:

  • Blood tests (liver function, blood counts)
  • Imaging scans to assess tumor response
  • Skin examinations for rash severity
  • Lung function tests if respiratory symptoms develop

Frequently Asked Questions (FAQs) About Erlonat 150mg (Erlotinib)

  1. How long does it take for Erlonat to work?

Response times can vary. Patients may notice improvement in their symptoms or shrinkage of tumors within a few weeks. But the full benefit can last several months.

  1. Can Erlonat cure cancer?

Erlonat does not provide the cure; however, it may decrease tumor growth and enhance longevity and quality of life for certain patients.

  1. What should I do if I miss a dose?

You should take the dose you missed whenever you can remember until’s moment for the next dose. Don’t double the dosage.

  1. Is Erlonat safe to take with food?

Erlonat must be consumed in the morning on an empty stomach to allow greater absorption. Do not eat for 1 hour before and for 2 hours following the drug.

  1. Why do I get a rash with Erlonat?

It is a frequent reaction that is linked to the way the drug acts on EGFR within skin cells. Most often, it is a sign that the drug is active. The doctor can prescribe treatment to treat the eruption.

  1. Can I drink alcohol while on Erlonat?

Alcohol can increase strain on the liver and cause worse negative effects. The best option is to stay clear of or reduce alcohol consumption while undergoing treatments.

  1. Are there any lifestyle changes I should make?

Beware of smoking cigarettes, shield your skin from sun damage, and follow your physician’s recommendations on nutrition and exercise.

  1. What happens if I experience severe side effects?

Call your physician immediately. Adjustments to dosage, delays in treatment, or even supportive treatment may be needed.

Conclusion

Erlonat 150mg (Erlotinib) is an effective targeted treatment that provides some hope for patients suffering from particular types of lung or pancreatic cancers. Inhibiting the EGFR pathway, Erlonat helps to slow cancer growth while improving health and quality of life.

Similar to any treatment for cancer, it is important to follow the correct dosage and be aware that the negative side effects, as well as regular checking, are vital to achieve optimal results. Regular communication with your healthcare team guarantees that any side symptoms or issues are dealt with quickly.

You or someone else you know was treated with Erlonat. Knowing the process and what you can expect will help make the process easier and effective.

Additional Information
Manufacturer

Natco Pharma

Pharmaceutical

Tablet/s

Strength

150 mg

Pack Size

30 Tablet/s, 60 Tablet/s

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Erlonat 150mg (Erlotinib)”

Your email address will not be published. Required fields are marked *

Are you human? Please solve:Captcha


Recently Viewed